Research and experimental development on natural sciences and engineering
SPRING BIOLAB AS
Revenue 2025
NOK 196,000
Operating profit
NOK 1,000
Equity
NOK 243,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2025
Current ratio
-254.16
Equity ratio
66.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 0.6% | |
| Net margin (%%) | 2.3% | |
| Return on assets (%%) | 0.3% | |
| Likviditet | ||
| Current ratio | -254.16 | |
| Working capital | 365k | |
| Soliditet | ||
| Equity ratio (%%) | 66.7% | |
| Debt-to-equity ratio | 0.50 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.